Abstract

2093P Bioelectrical Impedance phase angle and obesity as a prognostic indicator in metastatic gastric cancer patients receiving second-line chemotherapy

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Modified Glasgow Prognostic Score, Prognostic Nutritional Index and ECOG Performance Score Predicts Survival Better than Sarcopenia, Cachexia and Some Inflammatory Indices in Metastatic Gastric Cancer
Bülent Demirelli ... Perran Fulden Yumuk
Nutrition and Cancer | VOL. 73
Bülent Demirelli, et. al.Bülent Demirelli ... Perran Fulden Yumuk
09 Apr 2020
The influence of prior ramucirumab treatment on the clinical activity of FOLFIRI as third-line therapy in patients with metastatic gastric Cancer.
Giandomenico Roviello ... Pietro Rosellini
Investigational new drugs | VOL. 37
Giandomenico Roviello, et. al.Giandomenico Roviello ... Pietro Rosellini
28 Jan 2019
Comparison the efficacy of second-line modified EOX (epirubicin, oxaliplatin, and capecitabine) and irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) regimens in metastatic gastric cancer patients that progressed on first-line modified docetaxel and cisplatin plus fluorouracil (DCF) regimen.
Mehmet Ali Nahit Sendur ... Sercan Aksoy
Medical oncology and tumor pharmacotherapy | VOL. 31
Mehmet Ali Nahit Sendur, et. al.Mehmet Ali Nahit Sendur ... Sercan Aksoy
07 Aug 2014
FOLFIRI as a second-line therapy in patients with docetaxel-pretreated gastric cancer: a historical cohort
Marcello Maugeri-Saccà ... Silvia Ileana Fattoruso
Journal of Experimental & Clinical Cancer Research | VOL. 32
Marcello Maugeri-Saccà, et. al.Marcello Maugeri-Saccà ... Silvia Ileana Fattoruso
17 Sep 2013
View more papers

More From: Annals of oncology : official journal of the European Society for Medical Oncology

Paper Title
Journal
Date
Author
Neratinib and Ado-Trastuzumab-Emtansine for Pre-treated and Untreated HER2-positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium Trial 022
R.A Freedman ... N.U Lin
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. -
R.A Freedman, et. al.R.A Freedman ... N.U Lin
06 Jul 2024
Primary tumor resection for asymptomatic colorectal cancer with unresectable metastasis: the end of the dilemma
Sebastiano Biondo ... Esther Kreisler
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. -
Sebastiano Biondo, et. al.Sebastiano Biondo ... Esther Kreisler
03 Jul 2024
Challenging immune exhaustion in early recurrent triple-negative breast cancer: pitfalls and hopes
P Tarantino ... S M Tolaney
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 35
P Tarantino, et. al.P Tarantino ... S M Tolaney
01 Jul 2024
Elevating Cancer on the Global Health Agenda: Towards the 4th High-Level Meeting on NCDs 2025
Raffaella Casolino ... Andrè Ilbawi
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. -
Raffaella Casolino, et. al.Raffaella Casolino ... Andrè Ilbawi
01 Jul 2024
View more papers